Stein Adam B, Tang Xian-Liang, Guo Yiru, Xuan Yu-Ting, Dawn Buddhadeb, Bolli Roberto
Division of Cardiology and the Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40292, USA.
Stroke. 2004 Nov;35(11 Suppl 1):2676-9. doi: 10.1161/01.STR.0000143220.21382.fd. Epub 2004 Sep 30.
The early phase of preconditioning (PC) lasts 2 to 3 hours and protects against myocardial infarction, but not against stunning. In contrast, the late phase of PC lasts for 3 to 4 days and protects against both myocardial stunning and infarction, making this phenomenon more clinically relevant. Late PC is a genetic reprogramming of the heart that involves the activation of several stress-responsive genes, which ultimately results in the development of a cardioprotective phenotype. Sublethal ischemic insults release chemical signals (nitric oxide [NO], adenosine, and reactive oxygen species) that trigger a series of signaling events (eg, activation of protein kinase C, Src protein tyrosine kinases, Janus kinases 1/2, and nuclear factor-kappaB) and culminates in increased synthesis of inducible NO synthase, cyclooxygenase-2, heme oxygenase-1, aldose reductase, Mn superoxide dismutase, and probably other cardioprotective proteins. In addition to ischemia, heat stress, exercise, and cytokines can also induce a similar series of events. Perhaps most importantly, many pharmacologic agents (eg, NO donors, adenosine receptor agonists, endotoxin derivatives, or opioid receptor agonists) can mimic the effects of ischemia in inducing the late phase of PC, suggesting that this phenomenon might be exploited therapeutically. The purpose of this review is to summarize the mechanisms that underlie the late phase of ischemic PC.
预处理(PC)的早期阶段持续2至3小时,可预防心肌梗死,但不能预防心肌顿抑。相比之下,PC的晚期阶段持续3至4天,可预防心肌顿抑和梗死,这使得该现象在临床上更具相关性。晚期PC是心脏的一种基因重编程,涉及多个应激反应基因的激活,最终导致心脏保护表型的形成。亚致死性缺血损伤会释放化学信号(一氧化氮[NO]、腺苷和活性氧),这些信号会引发一系列信号事件(如蛋白激酶C、Src蛋白酪氨酸激酶、Janus激酶1/2和核因子κB的激活),最终导致诱导型NO合酶、环氧化酶-2、血红素加氧酶-1、醛糖还原酶、锰超氧化物歧化酶以及可能其他心脏保护蛋白的合成增加。除了缺血,热应激、运动和细胞因子也能诱导类似的一系列事件。也许最重要的是,许多药物制剂(如NO供体、腺苷受体激动剂、内毒素衍生物或阿片受体激动剂)可以模拟缺血在诱导PC晚期阶段的作用,这表明这种现象可能具有治疗应用价值。本综述的目的是总结缺血性PC晚期阶段的潜在机制。